Kite VP, Market Access

Kite Pharma, a Gilead company, was established in 2009 in Santa Monica, CA and quickly become the leading global cell therapy company, developing cancer immunotherapy products with a primary focus on genetically engineered autologous T cell therapy with chimeric antigen receptors. With its initial commercial cell therapy, Yescarta, Kite Pharma has provided more patients with long term remission, rapidly establishing commercial leadership in CAR T cell therapy. With an industry leading pipeline, the company is focused on the clinical and commercial development of innovative cancer immunotherapies.

Kite's Vision, Mission and Values

Kite is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. This is at the heart of everything it does, from early research to product development.

For the past three decades, members of the Kite team have been at the forefront of cancer immunotherapy. Today, Kite is the leader in engineered T cell therapy, changing the paradigm of cancer treatment with what is potentially the biggest breakthrough since the introduction of combination chemotherapy more than 60 years ago.

With an unrelenting drive and a singular focus on cell therapy, the team is executing on its strategy in order to bring life-saving therapies to patients.

To bring about this transformation, Kite is developing innovative products that harness a patient's own immune system to target and attack cancer cells. In just three years, Kite's singular focus and strategic collaborations have enabled us to advance an industry-leading pipeline of chimeric antigen receptor (CAR) and T cell receptor (TCR) product candidates to address both hematological (blood-based) and solid cancers

In pursuit of this ambitious vision and mission, employees at Kite embrace the following core values

• • Integrity Doing What's Right
  • Inclusion Encouraging Diversity
  • Teamwork Working Together
  • Accountability Taking Personal Responsibility
  • Excellence Being Your Best

The Vice President, US Market Access will lead the development and execution of the market access strategy for Yescarta and future Kite cellular therapies in the US, ensuring patients and providers have access to them. The successful candidate will have deep expertise in the US reimbursement system, across both public and private payers and all settings of care, as well as understanding of the unique and emerging reimbursement landscape for Oncology therapies and a curative treatment paradigm.

Key responsibilities will include, but not be limited to:

Experience and Qualifications

• 15+ years experience in Pharmaceutical/Biotech Commercial and Market Access roles, including a focus in Oncology. Experience in cell therapy a plus
• Ability to lead by example, attract and develop talent, build partnerships and create a culture of collaboration and high performing teams that fosters open communication, constructive feedback and organizational flexibility
• Requires ability to travel minimum of 50%
• Excellent strategic thinking skills, with demonstrated ability to successfully lead in a novel, dynamic environment
• Creativity and resilience in problem solving and a relentless, hands-on drive to implement and accomplish performance goals and objectives in a rapid-paced, changing business environment.
• Comfort with uncertainty and the ability to exercise sound judgment and determine appropriate action where precedent may not exist. The candidate should have a mindset toward innovation and non-traditional market access approaches when appropriate
• Outstanding written and verbal communication skills with the ability to effectively present to and engage with a wide range of audiences
• Sustained track record of achievement in developing Market Access strategies and leading teams to execute on the strategy
• Must have an undergraduate degree, with a relevant post graduate degree preferred

Kite is a biopharmaceutical company engaged in the development of innovative cancer immunotherapies with a goal of providing rapid, long-term durable response and eliminating the burden of chronic care. The company is focused on chimeric antigen receptor (CAR) and T cell receptor (TCR) engineered cell therapies designed to empower the immune system's ability to recognize and kill tumors. Kite is based in Santa Monica, CA. For more information on Kite, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability,genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contactcareers@gilead.comfor assistance.

For more information about equal employment opportunity protections, please view the'EEO is the Law'poster.

NOTICE: EMPLOYEE POLYGRAPH PROTECTION ACT
YOUR RIGHTS UNDER THE FAMILY AND MEDICAL LEAVE ACT

PAY TRANSPARENCY NONDISCRIMINATION PROVISION

Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Kite Pharma Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.